Correlation Between Cannara Biotech and Rubicon Organics

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Rubicon Organics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Rubicon Organics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Rubicon Organics, you can compare the effects of market volatilities on Cannara Biotech and Rubicon Organics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Rubicon Organics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Rubicon Organics.

Diversification Opportunities for Cannara Biotech and Rubicon Organics

0.16

Correlation Coefficient

Cannara Biotech  Rubicon Organics

Average diversification

The 3 months correlation between Cannara and Rubicon is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Rubicon Organics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rubicon Organics and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Rubicon Organics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rubicon Organics has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Rubicon Organics go up and down completely randomly.

Pair Corralation between Cannara Biotech and Rubicon Organics

Assuming the 90 days trading horizon Cannara Biotech is expected to generate 0.73 times more return on investment than Rubicon Organics. However, Cannara Biotech is 1.37 times less risky than Rubicon Organics. It trades about 0.24 of its potential returns per unit of risk. Rubicon Organics is currently generating about 0.05 per unit of risk. If you would invest  70.00  in Cannara Biotech on December 30, 2024 and sell it today you would earn a total of  60.00  from holding Cannara Biotech or generate 85.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  Rubicon Organics

Cannara Biotech

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Rubicon Organics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Rubicon Organics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Rubicon Organics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cannara Biotech and Rubicon Organics

The main advantage of trading using opposite Cannara Biotech and Rubicon Organics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Rubicon Organics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rubicon Organics will offset losses from the drop in Rubicon Organics' long position.

The idea behind Cannara Biotech and Rubicon Organics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.